New Report: Estimating the impact of schedule 3 consumer advertising

The Australian Self Medication Industry (ASMI) commissioned the Centre for Health Economics Research and Evaluation (CHERE), University of Technology Sydney to undertake a research project with the aim of evaluating the impact of advertising of Pharmacist Only (Schedule 3, S3) medicines on the choice and behaviour of consumers.

Download the report here (PDF 1.61MB)

Share
Share this on LinkedIn
Back to CHERE news
Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.